+7 (495) 505-52-05

" "





2013-06-04 20:44:47

. . . , . 250 . 2 . (34), , 500 . 2 . - ? ....
2013-05-15 20:22:14

10. 20. ? ...
2013-05-05 12:39:07

! 4 , , - , ?...
2013-04-24 10:50:26

! : , . : + + . , , , . 2- . - , . . . 3 ......
2013-04-18 21:36:56

! . 50 . . : - , - , . . . - . - , , . , . . ......

,
:

. ""

HEADING_TITLE_2
?
??
5 N50
- 1% 20 /
5/ 2 N10 / - /
- 1% 30 / Merckle
5/ 5 N10 / - /
/ + 21 / 200 Kneipp Gmbh
10 N30
/ / 200 Kneipp Gmbh
10 N30
/ / 200 Paul Hartmann
10 N90
/ 200 Paul Hartmann
10 / GlaxoSmithKline
/ / 50
30
/ 21 60 Kneipp Gmbh
N10
/ / 500 Kneipp Gmbh
50
/ 60 Kneipp Gmbh
N20 /
/ 500 Kneipp Gmbh
60 60 N100 Klocke Pharma-Service
/ 60 Kneipp Gmbh
100 N100
- 8956236 8 N2 Kneipp Gmbh
100 N112
- 21 8956237 8 N2 Kneipp Gmbh
200 N112
/ 20
15 N1 / - /
/ 100 Kneipp Gmbh
3 N1 / - /
/ / 200 Kneipp Gmbh
5 N1 / - /
/ / 200 Kneipp Gmbh
4% 10 N10 / - /
/ / 200 Kneipp Gmbh
40/ 10 N10 / - /
/ ( ) 203 Paul Hartmann
N50 Biologische Heilmittel Heel GmbH
( / + 21 200 + / + 21 200) Kneipp Gmbh
N120
/ / 500 Kneipp Gmbh
N30
/ ( ) 80 Kneipp Gmbh
N60
/ ( ) 80 Kneipp Gmbh
N120
/ ( ) 80 Kneipp Gmbh
N30
/ 500 Kneipp Gmbh
N60
/ ( ) 80 Kneipp Gmbh
N100
/ 60 Kneipp Gmbh
3 N30 -
- 160+12 5 N28
-3 N120
- 80+12 5 N28
-3 N120 -
- 0 625+2 N30 -
-3 N120
- 1 25+4 N30 -
-3 N60
- 1 25+4 N90 -
-3 N60 -
- 2 5+8 N90 -
-3 N60
- 10+160+12 5 N28
-3 N120
- 5+160+12 5 N28
-3 N60
150+12 5 N28
500 N30
300+12 5 N28
10% 10 N10 - /
300+25 N28
45 / -
250 10 N30 - Patheon France
- / 45 -
N10 -
4 N30
N20 -
10 Haupt Pharma Munster GmbH
100 -
/ 10
200 -
10% 40 - /
100 -
5
200 -
1% 15 - /
20 / -
1% 20
N10 // -
1% 20 - /
100 N28
1% 30
50 N14
1% 15
50 2 N5 / - /
-6 100 N6
N30 / Laboratoires Boiron
- 30+63
360 Colgate-Palmolive
H 100 Bionorica SE
360 Colgate-Palmolive
H N60 Bionorica SE
75 Colgate-Palmolive
9/600 / L/XL N5 Canpol Sp zo o
75 Colgate-Palmolive
/ 30
Colgate-Palmolive
+Q10 N40
100 Colgate-Palmolive
- / 75
/ 250 Colgate-Palmolive
N100
25 Colgate-Palmolive
N200
100 Colgate-Palmolive
N50
N10 Ranbaxy
50 N28
N12 GlaxoSmithKline
25 N28
N10 / - / GlaxoSmithKline
25 N40
N5 / - / GlaxoSmithKline
25 N56
N10 / - / - GlaxoSmithKline
30 /
N5 / - / GlaxoSmithKline
50 /
N5 / - / - GlaxoSmithKline
50 N40
N10 / - /
25 N20 Salutas Pharma
N5 / - /
25 N40 Salutas Pharma
N10 / - / / GlaxoSmithKline
- 25 N40
75
- 150 N1 / - / Pharmachemie
8 N7
N10
8 -D N7
N40
10 - / Heinrich Mack Nachf
12 5 N30
/ N100
6 25 N30
- 5 N5
25 N30 Salutas Pharma
2/+5/ 5
-OBL 12 5 N30
2 N10 - / -
- 12 5 N30
/ - 7 N10
- 25 N30
/ - 7 N10
- 6 25 N30
N30 -
- 12 5 N30 Teva Operations Poland Sp z o o
N60 -
- 25 N30 Teva Operations Poland Sp z o o
3 15000/ 10 / -
- 6 25 N30 Teva Operations Poland Sp z o o
N30 / -
100 N30
N30 / -
100 N60
N30 -
20 N20
N60 -
40 N20
4 5 N30
40 N50
N30 -
10 N30
N30 -
5 N30
45 N30 -
N40
N60 -
10
4 5 / N30
150+30 39 N100
3 43 / / -
150+30 39 N30
3 N100 -
75+15 2 N100
3 N30 -
75+15 2 N30
3 N30 -
100/ 5 N10 - /
3 N60 -
250 N40
3 N100 -
10 N28 -
3 N30 -
20 N28 -
N60 -
40 N28 -
N60 -
12 5+20 N28 -
N60 -
4 N30 Pfizer Manufacturing Deutschland
N60 -
350 N1 / - /
N30 -
50 -
N30 -
/ 30 -
N10 -
20 Dr A &L Schmidgall
N10 Swiss Caps
40 Dr A &L Schmidgall
N30 -
/ 75 Dr A &L Schmidgall
N60 -
/ / 75 Dr A &L Schmidgall
2 N10 - /
/ / 75 Dr A &L Schmidgall
2 N5 - /
/ / 75 Dr A &L Schmidgall
0 1% 15 /
/ // 75 Dr A &L Schmidgall
0 1% 15 /
75 Dr A &L Schmidgall
0 1% 30 /
75 Dr A &L Schmidgall
2 30
75 Dr A &L Schmidgall
142 43
- 75 Dr A &L Schmidgall
300 N50
- 75 Dr A &L Schmidgall
300 N50 -
25
300 N50
N20
500 N50
35 N180
10 N30 Merck KGaA
35 N80
10 N50 Merck KGaA
90 N30
5 N30 Merck KGaA
- - 100
5 N50 Merck KGaA
50 N28 Astrazeneca
10+5 N30
0 75 15 - +
5+5 N30
20 N28
2 5 N30 Merck KGaA
20 N5 / - /
/ 60
40 N14
/ 60
50
20 / Merz Pharma GmbH & Co KGaA
30 -
50 / Merz Pharma GmbH & Co KGaA
/ 75
20 N14
- / 6
40 N14
N20
40 N28
ͮ N40
- N50 Bayer Consumer Care AG
40 1 N5 / Bristol-Myers Squibb
- N502+N25 Bayer Consumer Care AG
4 N50
Bayer Consumer Care AG
1000 N30 UCB Pharma S p A
100+75 N28
100/ 300 - / NextPharma S a S
5 N56 Servier Laboratoires
250 N30 UCB Pharma S p A
7 5 N56 Servier Laboratoires
500 N60 UCB Pharma S p A
25 / -
10 N10 Industrias Farmaceuticas Almirall Prodes
N20
10 N5 Industrias Farmaceuticas Almirall Prodes
50 / -
20 N10 Industrias Farmaceuticas Almirall Prodes
200 N30
10 N100 Ranbaxy 1/10
10 N100
30/ 1 N10 - / /
20 N60
100 N60
25% 25 /
200 N60
25% 2 N10 - /
150
10 N90 Actavis Group
60
5 N30 Actavis Group
400 N5 -
5 N90 Actavis Group
200 N10 Mekophar Chemical-Pharmaceutical Joint
X 40 N20
100 N12 Lek
20 N30
100 N20
/ 40 Stafford Miller
150 N20
/ 40 Stafford Miller
2 5% 100 Lek
/ 40 Stafford Miller
2 5% 50 Lek
/ 70 Stafford Miller
5% 100 / Salutas Pharma
/ 40 Stafford Miller
5% 30 Lek
/ 40 Stafford Miller
5% 50 Lek
/ N30 Stafford Miller
50/ 2 N10 - / /
/ N30 Stafford Miller
150 N30
10 N100 Pliva Hrvatska d o o
N10
10 N50 Pliva Hrvatska d o o
100 N20
20 N50 Pliva Hrvatska d o o
2 5% 30 /
10 N60 Zentiva a s
2 5% 50 /
5 N30 Zentiva a s
2 5% 50 /
5 N60 Zentiva a s
50/ 2 N10 - /
10 (22) N10 / - /
- 2 5% 30 / Laboratories CHEMINEAU
5 (11) N10 / - /
- 2 5% 50 / Laboratories CHEMINEAU
25 N80
10 N20 - `
5% 60 - /
2% 30 Dr Reddy s Laboratories Ltd
5
2% 50 / Dr Reddy s Laboratories Ltd
120 N7
30/ 1 N10 - / / - `
N16 Kimberly-Clark
3% 1 N10 - /
N16 Kimberly-Clark
50 N100 Labesfal Laboratorios Almiro S A
N20 Kimberly-Clark
1 N30
N20 Kimberly-Clark
10 N20
N60 Kimberly-Clark
+ N30 Santa Cruz Nutritionals
N16 Kimberly-Clark
+ N60 Santa Cruz Nutritionals
N16 Kimberly-Clark
+ N30 Supplement Sciences Inc
N8 Kimberly-Clark
+ N60 Supplement Sciences Inc
N8 Kimberly-Clark
+ N30 Supplement Sciences Inc
N8 Kimberly-Clark
+ N60 Supplement Sciences Inc
N16 Kimberly-Clark
10 Dhu-Arzneimittel GmbH & Co KG
N8 Kimberly-Clark
/ /- N1
N10 Kimberly-Clark
/ / N1
N7 Kimberly-Clark
/ / N1
N8 Kimberly-Clark
/ / N1
- N10 Kimberly-Clark
/ / N1
- N10
/ // N1
Q10 0 5 N40
4 5
2 2 N5 - Biologische Heilmittel Heel GmbH
4 5
90 1 125 N15
4 5
1 5 N20 /
4 5
35
300 N5 / - /
15 N10
/ 20
30
N28 Bayer Weimar GmbH & Co KG
40
N283 Bayer Weimar GmbH & Co KG
45
650 N80 -Fitolon
75
10 N10 -
10000 N20 Abbott Laboratories GmbH
10 N30 -
10000 N50
1/ 60 -
25000 N20 Abbott Laboratories GmbH
250 N14
25000 N50
500 N14
10 N28 IPR Pharmaceuticals Inc
250 N14
20 N28 IPR Pharmaceuticals Inc
500 N14
5 N28 IPR Pharmaceuticals Inc
-OBL 500 N14
2% 10 -
- 500 N10 Pliva Hrvatska d o o
2 8/ 85 15 -
- 500 N14 Pliva Hrvatska d o o
50
125/5 60 / Abbott S p A
N2
250 N10 Abbott S p A
50
500 N14 Abbott S p A
N20 /
500 N5
- / 250
500 N7
- / 250
2 01 4
- / 50
-6 15 - /
- 75
20/0 2 N10 - /
- 50
40/0 4 N10 - /
- / 75
40/0 4 N10 - / 1/10
- / 150
60/0 6 N2 - /
- / - 100
80/0 8 N10 - /
- 200
0 02 N50
- / 200
1/ 100
- / 200
15
- / 250
/ 250
- / F 250
- 1+10/ 15
- / F 250
- 1+10/ 30
- 200
170
- 200
170
- F 200
50 Bionorica SE
2 5 Pfizer MFG Belgium N V
N60 Bionorica SE
0 005% 2 5 N3
N30 Bionorica SE
0 005% 2 5 N3 Pfizer MFG Belgium N V
10
0 005% 2 5 Pfizer MFG Belgium N V
N40 /
15 / Leo Laboratories Limited
- N50 / Biologische Heilmittel Heel GmbH
150 N60 -
N100 Dhu-Arzneimittel GmbH & Co KG
10 N30
N30 -
15 N28
N21
20 N100
N21 Bayer Schering Pharma AG
20 N28
/ 50
100 N28 -
/ / 50
120 N21 -
/ 50
120 N42 -
/ 50
120 N84 -
150 N16
8 N10
150/ 2 N10 - // /
8 N30
100 N3
8 N5 / - / /
2% 20
8 N12
2%+2% 20
5 N10 UCB Farchim
1% 30
5 N14 UCB Farchim
N10 Kimberly-Clark
5 N7 UCB Farchim
N1010 Kimberly-Clark 1/10
5/ 10 / UCB Pharma S p A
N80 Kimberly-Clark
0 05% 10
N10 Kimberly-Clark
0 1% 10
N10 Kimberly-Clark
0 1% 10
N42 Kimberly-Clark
0 05% 10
N712 Kimberly-Clark
0 1% 10
N50
0 05% 35/ 10
N50 1/10
0 1% 140/ 10
N50 1/50
140/ 10
510
84+70/ 10
714
Q10 3% 20 /
- 100 N10
Q10 N40
75 N14
Q10 20
75 N28
Q10 N20
- 75 N14
40
- 75 N28
250 N100
- 75 N28 Teva Pharmaceutical Works Co Ltd
N 75 N40 -
2 N50 /
CS1006 Curaden International AG
200/ 1 N1 - / /
203 Curaden International AG
50 N10
0 103% 15
1% 15 - / Medana Pharma
0 205% 10 - /
1% 20 / GlaxoSmithKline
40506